The IMPACT
Program Team
.jpeg)
Program Leadership
Dr. Hesham Abdelbary
MD, FRCSC, MSc - IMPACT Program Lead
Dr. Hesham Abdelbary is an orthopaedic surgeon at The Ottawa Hospital specializing in
musculoskeletal oncology and complex joint reconstruction. He is an Assistant Professor in the
Department of Surgery at the University of Ottawa and holds the Tier 2 Clinical Research Chair for
“Prosthetic Joint and Bone Infections” in the Faculty of Medicine. Dr. Abdelbary is also a scientist in the
Inflammation and Chronic Disease Program at the Ottawa Hospital Research Institute. He also holds a
cross appointment to the Clinical Science and Translational Medicine (CTM) graduate program at the
University of Ottawa. Dr. Abdelbary is also the director of the Implant Associated Infection translational
research program where he focuses on advancing patient care through innovative research,
interdisciplinary collaboration, and the translation of scientific discovery into clinical practice.
Research Team
The IMPACT Program is supported by an interdisciplinary group of clinicians, scientists, and trainees with expertise in bacterial biofilms, bacteriophage biology, translational research, and clinical trial design. The team works collaboratively across disciplines to advance innovative approaches to the prevention, diagnosis, and treatment of implant-associated infections.
Dr. Mariam Taha
PhD
Scientific Manger at Dr. Abdelbary’s laboratory. Specialized expertise in bacteriology, bacteriophage and biofilm biology. Actively involved in bacteriophage invivo and invitro studies, clinical trial development, and translational research. PhD in Microbiology from the University of Ottawa.
Dr. Yusra Al Mosuli
MD PhD
Clinical Research Associate. Coordinates the division’s orthopaedic oncology and bacteriophage clinical trials. Involved in several translational research projects in regenerative medicine and cancer therapeutics.
Het Vaishnav
MSc
Research Technician, focusing on animal models of PJI and therapeutics. MSc. in Cellular and Molecular Medicine from the University of Ottawa, researching early onset ovarian cancer among BRCA mutation carriers Well acquainted with primary cell isolation and culture, (immune) histological staining and histopathology.
Trusted Partner
Recognition That Fuels Us
2025
10x Featured Project
Behance
2024
Creator of the Year
Creative Awards
2023
7x Best Website Award
CSSDA
2022
2025 Rising Star
Webflow Community
2021
Excellence in UX Design
Design Leaders Summit
2020
Innovation in Digital Design
FWA
